PNC Financial Services Group’s Tenax Therapeutics TENX Stock Holding History
Bought
Maintained
Sold
Other funds holding TENX
PNC Financial Services Group's TENX Position: Q3 2026 in Review
PNC Financial Services Group opened a new position in Tenax Therapeutics (TENX) in Q3 2026: 6,066 shares worth $11.5K. The stake represents ﹤0.01% of the portfolio and ranks #4113 among its holdings. This is a return to the name: PNC Financial Services Group previously reported a position in TENX as recently as Q3 2022.
PNC Financial Services Group first reported a position in TENX in Q3 2021 and has held it in 6 quarters since. The position peaked at $208K in Q4 2021. 106 funds tracked by Wall St. Rank hold TENX as of Q3 2026.
- PNC Financial Services Group held 6,066 shares of Tenax Therapeutics worth $11.5K as of Q3 2026.
- Tenax Therapeutics was a new PNC Financial Services Group position in Q3 2026.
- Tenax Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4113 holding.
- PNC Financial Services Group first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 6 quarters since.
- PNC Financial Services Group's Tenax Therapeutics position peaked at $208K in Q4 2021.
- 106 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.